{"transactions":[{"id":874644,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":47387,"kind":"organization","name":"AI Biotechnology LLC","position":1,"cik":"0001942670","reported_name":"AI Biotechnology LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":2,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":3,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":4,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2026-03-02T22:55:03.000Z","date":"2026-02-26","kind":"purchase","planned":false,"acquired":true,"shares":2000000,"price":6.25,"value":12500000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of Class A Ordinary Shares acquired pursuant to a registered offering of Class A Ordinary Shares by the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A Ordinary Shares acquired pursuant to a registered offering of Class A Ordinary Shares by the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported are held directly by AI Biotechnology LLC (\"AIB\") and may be deemed to be beneficially owned by Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, and (iii) AIH owns all of the voting units of AIB. Each of AIH, AIM and Mr. Blavatnik, and each of their affiliated entities and the officers, partners, members and managers thereof, disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":6552725,"source":{"system":"sec-edgar","filing":"0001193125-26-085900","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1942670/000119312526085900/ownership.xml","form_type":"4"}},{"id":1385040,"issuer":{"id":5743,"kind":"organization","name":"Upstream Bio, Inc.","symbol":"UPB"},"owners":[{"id":86732,"kind":"organization","name":"AI Upstream LLC","position":1,"cik":"0002039907","reported_name":"AI Upstream LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47387,"kind":"organization","name":"AI Biotechnology LLC","position":2,"cik":"0001942670","reported_name":"AI Biotechnology LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":3,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":4,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":5,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2024-10-17T16:05:04.000Z","date":"2024-10-15","kind":"exercise","planned":true,"acquired":false,"shares":1172410,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A preferred stock and Series B preferred stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 1.049-for-one basis upon closing of the Issuer's initial public offering without payment of consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A preferred stock and Series B preferred stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 1.049-for-one basis upon closing of the Issuer's initial public offering without payment of consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A preferred stock and Series B preferred stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 1.049-for-one basis upon closing of the Issuer's initial public offering without payment of consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A preferred stock and Series B preferred stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 1.049-for-one basis upon closing of the Issuer's initial public offering without payment of consideration. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported are held directly by AI Upstream LLC (\"AI Upstream\") and may be deemed to be beneficially owned by AI Biotechnology LLC (\"AI Biotechnology\"), Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, (iii) AIH owns all of the voting units of AI Biotechnology and (iv) AI Biotechnology owns all of the voting units of AI Upstream. Each of the reporting persons (other than AI Upstream) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1172410},"source":{"system":"sec-edgar","filing":"0000950170-24-115295","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2039907/000095017024115295/ownership.xml","form_type":"4"}},{"id":1385039,"issuer":{"id":5743,"kind":"organization","name":"Upstream Bio, Inc.","symbol":"UPB"},"owners":[{"id":86732,"kind":"organization","name":"AI Upstream LLC","position":1,"cik":"0002039907","reported_name":"AI Upstream LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47387,"kind":"organization","name":"AI Biotechnology LLC","position":2,"cik":"0001942670","reported_name":"AI Biotechnology LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":3,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":4,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":5,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2024-10-17T16:05:04.000Z","date":"2024-10-15","kind":"exercise","planned":true,"acquired":false,"shares":3147000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A preferred stock and Series B preferred stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 1.049-for-one basis upon closing of the Issuer's initial public offering without payment of consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A preferred stock and Series B preferred stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 1.049-for-one basis upon closing of the Issuer's initial public offering without payment of consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A preferred stock and Series B preferred stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 1.049-for-one basis upon closing of the Issuer's initial public offering without payment of consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A preferred stock and Series B preferred stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 1.049-for-one basis upon closing of the Issuer's initial public offering without payment of consideration. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported are held directly by AI Upstream LLC (\"AI Upstream\") and may be deemed to be beneficially owned by AI Biotechnology LLC (\"AI Biotechnology\"), Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, (iii) AIH owns all of the voting units of AI Biotechnology and (iv) AI Biotechnology owns all of the voting units of AI Upstream. Each of the reporting persons (other than AI Upstream) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3147000},"source":{"system":"sec-edgar","filing":"0000950170-24-115295","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2039907/000095017024115295/ownership.xml","form_type":"4"}},{"id":1385038,"issuer":{"id":5743,"kind":"organization","name":"Upstream Bio, Inc.","symbol":"UPB"},"owners":[{"id":86732,"kind":"organization","name":"AI Upstream LLC","position":1,"cik":"0002039907","reported_name":"AI Upstream LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47387,"kind":"organization","name":"AI Biotechnology LLC","position":2,"cik":"0001942670","reported_name":"AI Biotechnology LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":3,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":4,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":5,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-17T16:05:04.000Z","date":"2024-10-15","kind":"exercise","planned":true,"acquired":true,"shares":1172410,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A preferred stock and Series B preferred stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 1.049-for-one basis upon closing of the Issuer's initial public offering without payment of consideration. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported are held directly by AI Upstream LLC (\"AI Upstream\") and may be deemed to be beneficially owned by AI Biotechnology LLC (\"AI Biotechnology\"), Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, (iii) AIH owns all of the voting units of AI Biotechnology and (iv) AI Biotechnology owns all of the voting units of AI Upstream. Each of the reporting persons (other than AI Upstream) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":5494410,"source":{"system":"sec-edgar","filing":"0000950170-24-115295","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2039907/000095017024115295/ownership.xml","form_type":"4"}},{"id":1385037,"issuer":{"id":5743,"kind":"organization","name":"Upstream Bio, Inc.","symbol":"UPB"},"owners":[{"id":86732,"kind":"organization","name":"AI Upstream LLC","position":1,"cik":"0002039907","reported_name":"AI Upstream LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47387,"kind":"organization","name":"AI Biotechnology LLC","position":2,"cik":"0001942670","reported_name":"AI Biotechnology LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":3,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":4,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":5,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-17T16:05:04.000Z","date":"2024-10-15","kind":"exercise","planned":true,"acquired":true,"shares":3147000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A preferred stock and Series B preferred stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 1.049-for-one basis upon closing of the Issuer's initial public offering without payment of consideration. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported are held directly by AI Upstream LLC (\"AI Upstream\") and may be deemed to be beneficially owned by AI Biotechnology LLC (\"AI Biotechnology\"), Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, (iii) AIH owns all of the voting units of AI Biotechnology and (iv) AI Biotechnology owns all of the voting units of AI Upstream. Each of the reporting persons (other than AI Upstream) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":4322000,"source":{"system":"sec-edgar","filing":"0000950170-24-115295","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2039907/000095017024115295/ownership.xml","form_type":"4"}},{"id":1385036,"issuer":{"id":5743,"kind":"organization","name":"Upstream Bio, Inc.","symbol":"UPB"},"owners":[{"id":86732,"kind":"organization","name":"AI Upstream LLC","position":1,"cik":"0002039907","reported_name":"AI Upstream LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47387,"kind":"organization","name":"AI Biotechnology LLC","position":2,"cik":"0001942670","reported_name":"AI Biotechnology LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":3,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":4,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":5,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-17T16:05:04.000Z","date":"2024-10-15","kind":"purchase","planned":true,"acquired":true,"shares":1175000,"price":17,"value":19975000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported are held directly by AI Upstream LLC (\"AI Upstream\") and may be deemed to be beneficially owned by AI Biotechnology LLC (\"AI Biotechnology\"), Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, (iii) AIH owns all of the voting units of AI Biotechnology and (iv) AI Biotechnology owns all of the voting units of AI Upstream. Each of the reporting persons (other than AI Upstream) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":1175000,"source":{"system":"sec-edgar","filing":"0000950170-24-115295","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039907/000095017024115295/ownership.xml","form_type":"4"}},{"id":2182285,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":1,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47387,"kind":"organization","name":"AI Biotechnology LLC","position":2,"cik":"0001942670","reported_name":"AI Biotechnology LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":3,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":4,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2022-08-17T20:03:13.000Z","date":"2022-08-15","kind":"purchase","acquired":true,"shares":4800000,"price":1.3125,"value":6300000.0,"ownership":{"direct":false,"nature":"By AI Biotechnology LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the purchase price of the ADSs divided by eight."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported are held directly by AI Biotechnology LLC (\"AIB\") and may be deemed to be beneficially owned by Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because Len Blavatnik controls AIM and controls a majority of the outstanding voting interests in AIH, AIM controls AIH, and AIH controls all of the outstanding voting interests in AIB. Each of the reporting persons (other than AIB) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":55911648,"source":{"system":"sec-edgar","filing":"0001209191-22-046214","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1942670/000120919122046214/doc4.xml","form_type":"4"}}]}